GlassScriptPhysician profile
Michael G Mercado
NPI 1558404616
$8,961.50
in general payments reported to CMS, 2019-2025
53 companies · $1,633 in 2025
The $1,633 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,178 · 2020: $764 · 2021: $1,842 · 2022: $1,207 · 2023: $1,173 · 2024: $1,164 · 2025: $1,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,940 · Education: $31.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,939.89 |
| Education | $31.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,481.84 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,126.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $831.48 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $683.99 | 2021-2025 | |
| Lilly USA, LLC | $577.41 | 2019-2025 | Mounjaro, Jardiance |
| Scilex Pharmaceuticals INC. | $495.46 | 2019-2024 | Ztlido |
| Pfizer INC. | $475.90 | 2019-2025 | |
| Glaxosmithkline, LLC. | $281.71 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.62 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $270.54 | 2019-2024 | Relistor |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $196.15 | 2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $160.77 | 2019 | |
| Amgen INC. | $144.92 | 2019-2025 | Repatha, Otezla, Otezla |
| Optinose US, INC. | $142.43 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $118.69 | 2024-2025 | Voquezna |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $116.16 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $113.14 | 2019-2023 | Seglentis |
| Clarus Therapeutics INC. | $109.64 | 2021 | |
| Horizon Therapeutics Plc | $87.81 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $81.23 | 2022-2023 | Rexulti |
| Lundbeck LLC | $79.68 | 2023-2025 | Rexulti |
| Amarin Pharma, INC. | $78.95 | 2019-2022 | |
| Protega Pharmaceutials INC | $70.49 | 2022-2023 | Roxybond |
| Astellas Pharma US INC | $62.01 | 2020-2024 | Veozah |
| Idorsia Pharmaceuticals US INC | $59.34 | 2022-2024 | Quviviq |
| Aimmune Therapeutics, INC. | $57.73 | 2025 | Zenpep |
| Almatica Pharma LLC | $53.55 | 2025 | Loreev Xr |
| Novartis Pharmaceuticals Corporation | $50.47 | 2022 | |
| Merck Sharp & Dohme LLC | $49.79 | 2019-2023 | Belsomra, Steglatro |
| Sunovion Pharmaceuticals INC. | $48.17 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $45.75 | 2022 | |
| Coala Life INC | $41.58 | 2023 | Coala Heart Monitor |
| Allergan, INC. | $40.72 | 2020 | |
| Daiichi Sankyo INC. | $39.23 | 2021-2022 | |
| Esperion Therapeutics, INC. | $39.01 | 2021-2024 | Nexletol |
| Biodelivery Sciences International, INC. | $33.73 | 2021 | |
| Sumitomo Pharma America, INC. | $33.32 | 2023-2024 | Gemtesa |
| Janssen Pharmaceuticals, INC | $31.07 | 2019-2020 | |
| Antares Pharma, INC. | $24.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.59 | 2019 | |
| Biogen, INC. | $23.30 | 2021 | |
| Abbott Laboratories | $23.02 | 2023 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $22.82 | 2022 | |
| Renalytix Ai, INC. | $22.70 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Medtronic, INC. | $21.91 | 2025 | Intellis Adaptivestim |
| Organogenesis INC. | $21.21 | 2023 | Puraply |
| Cashflow Solutions, LLC | $15.87 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Amneal Pharmaceuticals LLC | $14.51 | 2021 | |
| Hikma Pharmaceuticals USA | $14.43 | 2025 | Ryaltris |
| Ironshore Pharmaceuticals INC. | $12.70 | 2019 | |
| Mylan Specialty L.P. | $12.08 | 2020 | |
| Acerus Pharmaceuticals Corporation | $11.89 | 2022 | |
| Qorumpartners | $7.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mercado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.